Differences in the immune-inflammatory profiles of unipolar and bipolar depression (2020)
- Authors:
- USP affiliated authors: BRUNONI, ANDRE RUSSOWSKY - FM ; GATTAZ, WAGNER FARID - FM ; BENSEÑOR, ISABELA JUDITH MARTINS - FM ; LOTUFO, PAULO ANDRADE - FM ; LAFER, BENY - FM
- Unidade: FM
- DOI: 10.1016/j.jad.2019.10.037
- Subjects: TRANSTORNO BIPOLAR; DEPRESSÃO; INFLAMAÇÃO; CITOCINAS; BIOMARCADORES; TESTES IMUNOLÓGICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of affective disorders
- ISSN: 0165-0327
- Volume/Número/Paginação/Ano: v. 262, p. 8-15, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BRUNONI, André Russowsky et al. Differences in the immune-inflammatory profiles of unipolar and bipolar depression. Journal of affective disorders, v. 262, p. 8-15, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jad.2019.10.037. Acesso em: 03 jun. 2024. -
APA
Brunoni, A. R., Supasitthumrong, T., Teixeira, A. L., Vieira, E. L. M., Gattaz, W. F., Benseñor, I. J. M., et al. (2020). Differences in the immune-inflammatory profiles of unipolar and bipolar depression. Journal of affective disorders, 262, 8-15. doi:10.1016/j.jad.2019.10.037 -
NLM
Brunoni AR, Supasitthumrong T, Teixeira AL, Vieira ELM, Gattaz WF, Benseñor IJM, Lotufo PA, Lafer B, Berk M, Carvalho AF, Maes M. Differences in the immune-inflammatory profiles of unipolar and bipolar depression [Internet]. Journal of affective disorders. 2020 ; 262 8-15.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jad.2019.10.037 -
Vancouver
Brunoni AR, Supasitthumrong T, Teixeira AL, Vieira ELM, Gattaz WF, Benseñor IJM, Lotufo PA, Lafer B, Berk M, Carvalho AF, Maes M. Differences in the immune-inflammatory profiles of unipolar and bipolar depression [Internet]. Journal of affective disorders. 2020 ; 262 8-15.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jad.2019.10.037 - The Bipolar Depression Electrical Treatment Trial (BETTER): Design, Rationale, and Objectives of a Randomized, Sham-Controlled Trial and Data from the Pilot Study Phase
- Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial
- Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial
- Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study
- Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis.
- Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial
- A systematic review of non-invasive brain stimulation therapies and cardiovascular risk: implications for the treatment of major depressive disorder
- Cognitive control therapy and transcranial direct current stimulation for depression: A randomized, double-blinded, controlled trial
- Polarity- and valence-dependent effects of prefrontal transcranial direct current stimulation on heart rate variability and salivary cortisol
- The Influence of Skin Redness on Blinding in Transcranial Direct Current Stimulation Studies: A Crossover Trial
Informações sobre o DOI: 10.1016/j.jad.2019.10.037 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
